LexDanaLexDanabeta
Inventor

Patrick René Angibaud

Inventor
Fontaine-Bellenger, FR

Overview

96→
Patents
1999–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 96 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds33%
A61KPreparations for medical, dental or toiletry purposes23%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms5%
Y02ATechnologies for adaptation to climate change2%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
Y02PClimate change mitigation technologies in the production or processing of goods1%
C07BGeneral methods of organic chemistry0%
PatentTitleYear
11,130,751Quinoxaline and pyridopyrazine derivatives as PI3K-beta inhibitors202110,975,100Fused bicyclic inhibitors of menin-MLL interaction202110,894,793Bicyclic pyridine, pyrazine, and pyrimidine derivatives as PI3K beta inhibitors202110,745,409Azepane inhibitors of menin-MLL interaction202010,611,778Fused bicyclic inhibitors of menin-MLL interaction202010,526,316Quinoxaline and pyridopyrazine derivatives as PI3Kb inhibitors202010,519,137Pyrazolyl quinoxaline kinase inhibitors201910,272,087Pteridines as FGFR inhibitors201910,202,387Heterocyclyl linked imidazopyridazine derivatives as PI3KB inhibitors201910,087,187Imidazopyridazine derivatives as PI3KB inhibitors201810,045,982Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitors201810,039,759Quinolines as FGFR kinase modulators201810,004,733Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitors20189,856,236'Substituted quinoxalines as FGFR kinase inhibitors'20189,850,228Pyrazolyl quinoxaline kinase inhibitors20179,757,364'Naphthyridine derivative compounds'20179,737,544'Compounds'20179,636,341'Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase'20179,598,396'Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors'20179,556,161'Inhibitors of histone deacetylase'20179,533,979'Amino-derivatives as novel inhibitors of histone deacetylase'20179,527,844'Naphthyridine derivative compounds'20169,493,426'Quinazolinone derivatives useful as FGFR kinase modulators'20169,464,071'Pyrazolyl quinoxaline kinase inhibitors'20169,447,098'Pteridines as FGFR inhibitors'20169,439,896'Quinolines as FGFR kinase modulators'20169,309,242'Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitors'20169,309,241'Naphthyridine derivative compounds'20169,303,030'Compounds'20169,290,478'Substituted quinoxalines as FGFR kinase inhibitors'20169,150,560'Inhibitors of histone deacetylase'20159,150,540'Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as parp and tubulin polymerization inhibitors'20159,150,543'Substituted indolyl alkyl amino derivatives as inhibitors of histone deacetylase'20159,145,394'Substituted quinoxalines as FGFR kinase inhibitors'20159,078,896'Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase'20158,916,554'Amino-derivatives as novel inhibitors of histone deacetylase'20148,895,601'Pyrazolyl quinoxaline kinase inhibitors'20148,889,866'Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors'20148,796,244'Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases'20148,778,966'Quinolinone derivatives as PARP and tank inhibitors'20148,697,717'Inhibitors of histone deacetylase'20148,664,223'Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase'20148,592,441'Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase'20138,524,711'Amino-derivatives as novel inhibitors of histone deacetylase'20138,524,728'Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase'20138,513,237'Sulfonylamino-derivatives as novel inhibitors of histone deacetylase'20138,476,289'Aza-bicyclohexyl substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylace'20138,455,498'Inhibitors of histone deacetylase'20138,426,416'Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase'20138,404,713'Quinolinone derivatives as PARP inhibitors'20138,377,935'Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase'20138,343,988'Inhibitors of histone deacetylase'20138,329,714'Farnesyl transferase inhibiting 1,2-annelated quinoline enantiomer'20128,318,753'Farnesyl transferase inhibiting 1,2-annelated quinoline enantiomer'20128,299,256'Quinolinone derivatives as PARP and TANK inhibitors'20128,268,833'Inhibitors of histone deacetylase'20128,193,205'Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase'20128,168,644'Quinazolinone derivatives as tubulin polymerization inhibitors'20128,163,733'Sulfonylamino-derivatives as novel inhibitors of histone deacetylase'20128,163,765'Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase'20128,138,198'Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase'20128,119,650'Aminophenyl derivatives as novel inhibitors of histone deacetylase'20128,114,876'Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase'20128,101,616'Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase'20127,947,830'Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase'20117,943,635'Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors'20117,888,360'Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase'20117,834,025'Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase'20107,834,011'Heterocyclylalkyl derivatives as novel inhibitors of histone deacetylase'20107,816,363'Inhibitors of histone deacetylase'20107,767,679'Sulfonylamino-derivatives as novel inhibitors of histone deacetylase'20107,655,654'Farnesyl transferase inhibiting tricyclic quinazoline derivatives substituted with carbon-linked imidazoles or triazoles'20107,615,553'Inhibitors of histone deacetylase'20097,572,916'Diastereoselective synthesis process with 6-bromo-4-(3-chlorophenyl)-2-methoxy-quinoline'20097,541,369'Amino-derivatives as novel inhibitors of histone deacetylase'20097,524,961'Diastereoselective addition of lithiated N-methylimidazole on sulfinimines'20097,511,138'Farnesyl transferase inhibiting tricyclic quinazoline derivatives substituted with carbon-linked imidazoles or triazoles'20097,456,287'Diastereoselective synthesis process for the preparation of imidazole compounds'20087,408,063'1,8-annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitors'20087,241,777'Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors'20077,196,094'Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives'20077,173,040'Farnesyl transferase inhibiting 6-[(substituted phenyl)methyl]-quinoline and quinazoline derinazoline derivatives'20077,153,958'Farnesyl transferase inhibiting benzoheterocyclic derivatives'20067,129,356'Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives'20067,067,531'Farnesyl transferase inhibiting 6-heterocyclylmethyl quinolinone derivatives'20067,053,105'Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors'20066,914,066'1,2-annelated quinoline derivatives'20056,458,800'1,2-annelated quinoline derivatives'20026,444,812'Intermediate compounds in the preparation of farnnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N-or C linked imidazoles'20026,420,387'Farnesyl protein transferase inhibiting (imidazol-5-yl) methyl-2-quinolinone derivatives'20026,358,961'Farnesyltransferase inhibiting quinazolinones'20026,187,786'Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles'20016,177,432'Farnesyltransferase inhibiting quinazolinones'20016,169,096'Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives'20016,037,350'Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quionlinone derivatives'20005,968,952'Farnesyl transferase inhibiting 2-quinolone derivatives'1999

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1999–2021Patents assigned to JANSSEN PHARMACEUTICA NV (70)· patent assignee history
1999–2019Based in Fontaine-Bellenger, FR· patent location history
2006–2014Patents assigned to ANGIBAUD PATRICK RENE (24)· patent assignee history
2006–2021Based in Issy les Moulineaux, FR· patent location history
2012–2013Patents assigned to PILATTE ISABELLE NOELLE CONSTANCE (13)· patent assignee history
2012–2014Patents assigned to ROUX BRUNO (10)· patent assignee history
2013–2017Based in Fontaine, FR· patent location history
2014–2019Patents assigned to ASTEX THERAPEUTICS LTD (19)· patent assignee history
2016Based in Val de Reuil, FR· patent location history
2018–2021Based in Saint Pierre d'Autils, FR· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
JANSSEN PHARMACEUTICA NV701999–2021
ANGIBAUD PATRICK RENEself242006–2014
ASTEX THERAPEUTICS LTD192014–2019
PILATTE ISABELLE NOELLE CONSTANCE132012–2013
ROUX BRUNO102012–2014
Locations
LocationPatentsSpan
Fontaine-Bellenger, FR831999–2019
Saint Pierre d'Autils, FR62018–2021
Fontaine, FR32013–2017
Issy les Moulineaux, FR22006–2021
Val de Reuil, FR12016